Latest news, press releases, and SEC filings for Vanda Pharmaceuticals Inc (VNDA) https://caymanjournal.com/stock/VNDA en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 20:30:29 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 Here's a clear breakdown of Vanda Pharmaceuticals' DEF 14A proxy statement, explaining what it means for investors: # 📄 What This Document Is * This is the **Definitive Proxy Statement (DEF 14A)** for Vanda Pharmaceuticals' 2026 Annual Meeting of Stockholders. * It details the proposals stockh https://caymanjournal.com/stock/VNDA/sec-filing/0001628280-26-026893 https://caymanjournal.com/stock/VNDA/sec-filing/0001628280-26-026893 Thu, 23 Apr 2026 00:00:00 GMT SEC Filing